[HTML][HTML] Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L …
JF Timp, SK Braekkan, WM Lijfering… - PLoS …, 2019 - journals.plos.org
Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
JF Timp, SK Braekkan, WM Lijfering… - PLoS Medicine, 2019 - go.gale.com
Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
JF Timp, SK Brækkan, WM Lijfering… - 2019 - munin.uit.no
Background-Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
JF Timp, SK Braekkan, WM Lijfering… - PLoS …, 2019 - search.ebscohost.com
Recurrent venous thromboembolism (VTE) is common. Current guidelines suggest that
patients with unprovoked VTE should continue anticoagulants unless they have a high …
patients with unprovoked VTE should continue anticoagulants unless they have a high …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
JF Timp, SK Braekkan, WM Lijfering… - Plos …, 2019 - europepmc.org
Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
JF Timp, SK Braekkan, WM Lijfering… - PLoS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
JF Timp, SK Braekkan, WM Lijfering… - PLOS …, 2019 - econpapers.repec.org
Background: Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
[引用][C] Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L …
JF Timp, SK Braekkan, WM Lijfering, AV Vlieg… - 2019 - scholarlypublications …
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event:
The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) | Scholarly Publications …
The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) | Scholarly Publications …
[PDF][PDF] Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L …
JF Timp, SK Braekkan, WM Lijfering… - PLoS …, 2019 - pdfs.semanticscholar.org
Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …
[引用][C] Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L …
JF Timp, SK Braekkan, WM Lijfering… - PLOS Medicine, 2019 - cir.nii.ac.jp
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event:
The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) | CiNii Research CiNii …
The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) | CiNii Research CiNii …